Effects of Taping on Pregnancy-related Back Pain
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03807908 |
|
Recruitment Status : Unknown
Verified July 2019 by Carol Ann Weis, Canadian Memorial Chiropractic College.
Recruitment status was: Not yet recruiting
First Posted : January 17, 2019
Last Update Posted : July 25, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pregnancy Low Back Pain Pelvic Girdle Pain | Other: Tape Other: Sham Tape | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 96 participants |
| Allocation: | Randomized |
| Intervention Model: | Single Group Assignment |
| Intervention Model Description: | The study will be a randomized clinical trial. As none of the current research delineates the 3 pains during pregnancy, it would be beneficial to further investigate the use of tape for LBP, PGP or combined pain during pregnancy. As such, the participants will be stratified upon pain presentation (via history and physical exam) and then randomized into either a treatment or sham protocol. |
| Masking: | Single (Participant) |
| Masking Description: | Once consent has been obtained the senior chiropractors will review the intake questionnaire with the patients, ask any pertinent questions they may have regarding the patient's personal medical history and current pain pattern and perform a physical exam to differentiate pain patterns for each participant. Following completion of baseline assessment and consent, participants will be stratified by their type of pain presentation and then be randomly allocated to 1 of the 2 intervention arms. Central randomization will be performed using stratified block randomization by the study biostatistician (SHJ) using SAS software*. To ensure that the allocation sequence is concealed from the researchers varying block sizes of 2, 4 and 6 will be used and the biostatistician will provide the trial coordinator with 3 series (1 for each stratum) of sequentially numbered sealed opaque envelopes containing the intervention allocations. |
| Primary Purpose: | Treatment |
| Official Title: | The Short-term Effects of Taping During Pregnancy-related Low Back Pain, Pelvic Girdle Pain or Combined Pain |
| Estimated Study Start Date : | July 31, 2019 |
| Estimated Primary Completion Date : | July 2020 |
| Estimated Study Completion Date : | July 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention Tape
The intervention includes 3 strips of tape; 2 (1 on each side) placed vertically along the lumbar erectors and 1 horizontally at the posterior superior iliac spine. Subjects will wear the tape for as long as possible up to 5-7 days. |
Other: Tape
The patient will be placed into maximal flexion of the lumbar spine prior to the tape being applied. The vertical strips will be applied on either side of spine, on the erector muscle group; from the lower PSIS with and end around the twelfth rib. The third strip of tape will be applied horizontally to superior to the posterior superior iliac spines (PSIS) and extend over the 2 vertical strips of tape. The tape will be gently rubbed to activate the adhesive. Five to 7 days later, one of the investigators will follow up with the subjects over the phone and administer a questionnaire that will assess their experience with the tape as well as the outcome measures (numeric rating scale and Oswestry Disability Index). Other Name: Kinesiotape |
|
Sham Comparator: Sham Tape
One strip of tape will be applied horizontally to the thoracolumbar junction. Subjects will wear the tape for as long as possible up to 5-7 days. |
Other: Sham Tape
One strip of tape will be applied horizontally to the thoracolumbar junction (at the level of the lower rib cage over the T12-L1 spinous processes) with no tape-tension. The tape will be gently rubbed to activate the adhesive. Five to 7 days later, one of the investigators will follow up with the subjects over the phone and administer a questionnaire that will assess their experience with the tape as well as the outcome measures (numeric rating scale and Oswestry Disability Index). Other Name: Kinesiotape |
- Change from baseline Numeric Pain Scale (Pain) to Numeric Pain Scale (Pain) 5-7 days later [ Time Frame: 7 days ]Intensity of pain on a 0-10 scale; 0=no pain; 10=most severe pain
- Change from baseline Oswestry Back Disability Index (ODI) to ODI 5-7 days later [ Time Frame: 7 days ]Measure of a patient's functional disability
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | Participants must be experiencing a healthy, non-complicated pregnancy |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy females of childbearing age
- Currently experiencing a healthy, singleton pregnancy and are at 28 weeks of gestation or later
- Proficient competency in the English language
Exclusion Criteria:
- Does not wish to participate
- Carrying multiples
- Inability to understand the questionnaire due to a lack of understanding of the English language
- Allergy to tape and/or adhesives (acrylic copolymer)
- Prior spinal surgery
- A known and current disc pathology
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03807908
| Contact: Carol Ann Weis, MSc, DC | 416 738 2058 | cweis@cmcc.ca | |
| Contact: Mark Fillery, MSc | 416 482 2340 | mfillery@cmcc.ca |
| Principal Investigator: | Carol Ann Weis, MSc, DC | Canadian Memorial Chiropractic College |
| Responsible Party: | Carol Ann Weis, Researcher, Canadian Memorial Chiropractic College |
| ClinicalTrials.gov Identifier: | NCT03807908 |
| Other Study ID Numbers: |
182028 |
| First Posted: | January 17, 2019 Key Record Dates |
| Last Update Posted: | July 25, 2019 |
| Last Verified: | July 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Pregnancy Low back pain Pelvic girdle pain Kinesiotape |
|
Back Pain Low Back Pain Pelvic Girdle Pain Pain |
Neurologic Manifestations Musculoskeletal Pain Pelvic Pain |

